Chronology of Committee Work

Chairman Waxman Expands Toxic Trailers Investigation

In letters sent to FEMA Administrator R. David Paulison and three manufacturers of FEMA travel trailers, Chairman Waxman requested explanations for the high levels of formaldehyde in FEMA trailers and additional information about FEMA’s handling of the toxic trailers.

Members Ask Rural Utility Service How it is Protecting Taxpayer Subsidized Loans from the Financial Risks of Climate Change

In a letter to the Rural Utilities Service, Chairman Waxman and Rep. Jim Cooper asked how RUS is addressing the financial risks of building new coal-fired power plants without emissions controls for greenhouse gases, when RUS provides taxpayer-subsidized loans for such plants. Failure to account for costs these plants may face for future carbon controls would put taxpayer dollars at risk.

Committee Holds Second Day of Hearings on the Mitchell Report and Steroids in Baseball

The full Committee held a hearing entitled “The Mitchell Report: The Illegal Use of Steroids in Major League Baseball, Day 2.” This hearing examined allegations of steroid use by Roger Clemens and several other major league players that appeared in Senator George Mitchell’s Report to the Commissioner of Baseball of an Independent Investigation into the Illegal Use of Steroids and Other Performance Enhancing Substances by Players in Major League Baseball.

Committee Holds Hearing on Myths and Facts about Human Growth Hormone, B12, and Other Substances

The full Committee held a hearing at 10:00 a.m. to examine the myths and facts about performance-enhancing substances such as human growth hormone, B12 and other substances.

Chairman Waxman Releases Letter to Rusty Hardin

Chairman Waxman wrote to Rusty Hardin about his recent comments.

Committee Subpoenas Iraq Embassy Documents

Responding to the State Department’s repeated failure to provide documents, the Oversight Committee issued a subpoena seeking documents related to construction and safety problems at the new U.S. Embassy in Iraq.

Chairman Waxman Issues a Subpoena for EPA Presentations

Chairman Waxman issued a subpoena to compel the EPA to provide unredacted copies of a key presentation EPA staff made to Administrator Johnson in October 2007 about California’s regulations to reduce greenhouse gas emissions from automobiles.

Chairman Waxman Urges EPA to Protect Air Quality Near National Parks

In a letter to EPA Administrator Stephen Johnson, Chairman Waxman urged the agency to reject a proposed rule that would make it easier to build large, new polluting facilities near national parks and wilderness areas without installing adequate pollution controls. Chairman Waxman also requested an explanation of how the flawed proposal was approved and why the concerns identified by EPA’s key technical staff were ignored.

Members Call on the Science Board to Assess Resources Needed to Remedy FDA's Funding Crisis

Reps. Henry A. Waxman, John D. Dingell, Bart Stupak, and Frank Pallone, Jr., called on members of one of FDA’s own advisory committees to provide Congress with its assessment of the resources needed to remedy the crisis at the agency stemming from years of chronic underfunding.

Chairman Waxman Requests GAO Examination of Regional Fishery Management Council Expenditures

Chairman Waxman wrote to Comptroller General David Walker to request that GAO examine the expenditures of the Western Pacific Regional Fishery Management Council (WESPAC) in response to concerns about WESPAC’s questionable usage of federal funds.

Chairman Waxman Requests Progress Update on Greenhouse Gas Regulations

Chairman Waxman wrote to EPA Administrator Johnson to request an update on the agency’s progress in implementing controls on greenhouse gas emissions.

Chairman Waxman Requests Unredacted EPA Documents

In a letter to EPA Administrator Stephen Johnson, Chairman Waxman requests complete, unredacted copies of Administrator Johnson’s briefing slides regarding California’s petition for a Clean Air Act waiver to reduce greenhouse gas emissions from motor vehicles.

Chairman Waxman Requests Briefing on Inspections of Chinese Drug Manufacturer

In a letter to FDA Commissioner von Eschenbach, Chairman Waxman requested a briefing on FDA inspections of all facilities owned by the Shanghai Pharmaceutical Group that produce drugs for the United States. The Chinese company is currently under criminal investigation in China for the production of tainted leukemia drugs and manufactures at least one drug for export to the United States.

Oversight Committee Requests Executive Compensation Information from Fortune 250 Companies

The Oversight and Government Reform Committee is asking the compensation committee chairs of each of the Fortune 250 companies to provide information about how executive compensation consultants are utilized by these corporations in setting executive pay. This inquiry is part of an ongoing investigation into the role played by compensation consultants at large publicly traded corporations. In December 2007, the Committee held a hearing and released a report on this subject.

Committee Requests Information Regarding DOD Greenhouse Gas Emission Compliance

Chairman Waxman and Ranking Member Davis requested information from Secretary Gates on how the Department of Defense will comply with a recently enacted provision of law barring the government from purchasing alternative fuels for vehicles and planes, such as fuels from a coal-to-liquids process or tar sands, if those fuels have higher greenhouse gas emissions than conventional fuels.

Waxman and Kennedy Request GAO Examination of FDA Resource Shortfalls

Today Rep. Henry A. Waxman and Sen. Edward M. Kennedy wrote to Comptroller General of the United States David Walker requesting an examination of the staffing, information technology, and other resources necessary for the Food and Drug Administration (FDA) to successfully carry out its oversight of foods, drugs, biologics, and medical devices.

Full Committee Business Meeting on January 29, 2008

The full Committee held a business meeting to consider postal naming and commemorative bills.

Full Committee Holds Hearing on CDC Program Providing Breast and Cervical Cancer Screening

The full Committee held a hearing on “Addressing the Screening Gap: The National Breast and Cervical Cancer Early Detection Program.” The hearing examined the National Breast and Cervical Cancer program which is administered by the Centers for Disease Control and Prevention (CDC) to provide mammograms, pap smears, and other screening exams for breast and cervical cancer to low-income women without another source of coverage.

Committee Releases Updated Schedule of Depositions and Interviews for Major League Baseball Players

Today the Oversight and Government Reform Committee released an updated schedule of depositions and interviews related to allegations in Senator Mitchell’s Report to the Commissioner of Baseball of an Independent Investigation into the Illegal Use of Steroids and Other Performance Enhancing Substances by Players in Major League Baseball.

Update: The deposition previously scheduled for Tuesday, January 29, has been rescheduled to Friday, February 1.

Update: The deposition previously scheduled for Wednesday, January 30, has been rescheduled to Monday, February 4.

Members of Congress Question FDA Proposal Designed to Create Liability Shield for Drug and Device Companies

Today Representatives Henry A. Waxman, John D. Dingell, Frank Pallone, Jr., Rosa L. DeLauro, and Edward Markey, and Senators Edward M. Kennedy, Patrick J. Leahy, and Christopher J. Dodd, questioned the basis for a new Food and Drug Administration (FDA) proposal that was apparently designed to shield pharmaceutical and device companies from liability for injuries sustained by American consumers as a result of unsafe products.

Chairman Waxman Requests FDA Provide Documents Regarding Drug Company Marketing Loophole

On January 22, Chairman Waxman wrote to FDA Commissioner von Eschenbach requesting documents related to the FDA’s draft guidance allowing drug companies to use journal articles to promote potentially dangerous off-label uses of drugs and medical devices without prior FDA review and approval. According to FDA minutes of a meeting, Dan Troy and other drug company representatives urged FDA to issue guidance to protect the companies from “Federal prosecutors pursuing distributors of this information for criminal conduct.”

Chairman Waxman Schedules Hearing to Examine Preservation of White House E-mails

On February 26, the Committee will hold a hearing to investigate White House compliance with the Presidential Records Act. Statements made at the January 17 White House press briefing contradict information provided to the Committee, which revealed that a 2005 White House analysis found no archived mail for hundreds of days between 2003 and 2005.

Investigation into Mortgage CEO Compensation Expands

As part of its ongoing investigation into executive pay, the Oversight Committee asked Countrywide Financial, Citigroup, and Merrill Lynch to provide documents relevant to the compensation of Angelo R. Mozilo, Charles Prince and E. Stanley O’Neal.

In addition, the Committee invited the chairs of the compensation committees at these companies to testify on March 7 about how the compensation and severance packages for these executives were determined and on what basis they were approved.

Update: The hearing previously scheduled for February 7 has been rescheduled to March 7.

Committee Requests Action Plans for Uranium Contamination in the Navajo Nation

In letters to five federal agencies, Chairman Waxman and Ranking Member Davis request that the agencies prepare and submit five-year action plans for cleaning up the widespread uranium contamination in the Navajo Nation.

Hearing on Steroids in Major League Baseball and the Mitchell Report

The full Committee held a hearing entitled “The Mitchell Report: The Illegal Use of Steroids in Major League Baseball.” This hearing examined Senator George Mitchell’s investigation into the illegal use of steroids in Major League Baseball.

Displaying Items 176 to 200 of 1351:

Previous Page • Next Page

[1] • [2] • [3] • [4] • [5] • [6] • [7] • [8] • [9] • [10] • [11] • [12] • [13] • [14] • [15] • [16] • [17] • [18] • [19] • [20] • [21] • [22] • [23] • [24] • [25] • [26] • [27] • [28] • [29] • [30] • [31] • [32] • [33] • [34] • [35] • [36] • [37] • [38] • [39] • [40] • [41] • [42] • [43] • [44] • [45] • [46] • [47] • [48] • [49] • [50] • [51] • [52] • [53] • [54] • [55]